NCT04039022 Open-Label Safety Study of AXS-05 in Subjects With Depression Status COMPLETED Phase PHASE3
NCT04037111 Clinical Study of Escitalopram Oxalate Combined With taVNS in Depression and Concomitant Inflammatory Symptoms Status UNKNOWN Phase NA
NCT04032301 Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans Status COMPLETED Phase PHASE1
NCT04032015 rTMS Study in Depression to Evaluate the Relationship Between Brain Plasticity and Clinical Outcome Status WITHDRAWN Phase NA
NCT04031157 Controlled Study to Evaluate the Safety and Efficacy of the Predictix Antidepressant Clinician Support Tool Status UNKNOWN Phase NA
NCT04019704 A Trial of AXS-05 in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT04007367 A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder Status TERMINATED Phase PHASE3
NCT04000022 Repetitive Transcranial Magnetic Stimulation in Pharmaco-naïve Patients With Major Depression Status UNKNOWN Phase N/A
NCT03999736 Biomarkers of Response to Treatment With Frontal Cortex Stimulation for Anxious Depression Status TERMINATED Phase PHASE1/PHASE2
NCT03979040 Comparing Group Therapies for Veterans With Depression and PTSD Status COMPLETED Phase NA
NCT03977038 Investigation of the Effects of Repetitive Transcranial Magnetic Stimulation on Cognition in Depression Status COMPLETED Phase N/A
NCT03973268 Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression Status RECRUITING Phase PHASE1